Skip to content Skip to left sidebar Skip to footer

RSV Townhall to Discuss Nirsevimab

RSV Townhall to Discuss Nirsevimab

Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program. 

The townhall will take place over Zoom on Tuesday August 29 at 12pm.

Nirsevimab will be available to order through the VFC Program this fall. Prepare your practice for ordering and administration of the product at next week’s townhall. 

View past email advisories and keep up with important events on our website. We look forward to seeing you soon!